AU2003243806A1 - Lipid oxidation products for inhibiting inflammation - Google Patents

Lipid oxidation products for inhibiting inflammation

Info

Publication number
AU2003243806A1
AU2003243806A1 AU2003243806A AU2003243806A AU2003243806A1 AU 2003243806 A1 AU2003243806 A1 AU 2003243806A1 AU 2003243806 A AU2003243806 A AU 2003243806A AU 2003243806 A AU2003243806 A AU 2003243806A AU 2003243806 A1 AU2003243806 A1 AU 2003243806A1
Authority
AU
Australia
Prior art keywords
oxidation products
lipid oxidation
inhibiting inflammation
inflammation
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243806A
Other languages
English (en)
Inventor
Bernd Binder
Valery Bochkov
Norbert Leitinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003243806A1 publication Critical patent/AU2003243806A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003243806A 2002-07-15 2003-07-15 Lipid oxidation products for inhibiting inflammation Abandoned AU2003243806A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT10612002 2002-07-15
ATA1061/2002 2002-07-15
PCT/AT2003/000198 WO2004006910A1 (de) 2002-07-15 2003-07-15 Lipidoxidationsprodukte zur hemmung von entzündungen

Publications (1)

Publication Number Publication Date
AU2003243806A1 true AU2003243806A1 (en) 2004-02-02

Family

ID=30004252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243806A Abandoned AU2003243806A1 (en) 2002-07-15 2003-07-15 Lipid oxidation products for inhibiting inflammation

Country Status (2)

Country Link
AU (1) AU2003243806A1 (de)
WO (1) WO2004006910A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059082A1 (en) * 2004-11-30 2006-06-08 Trigen Limited Oxidised lipids as reversal agents for boronic acid drugs
WO2008154008A1 (en) * 2007-06-11 2008-12-18 The Scripps Research Institute Methods and compositions for inhibiting toll-like receptor mediated immune responses
WO2013107839A2 (en) * 2012-01-20 2013-07-25 Technische Universität Graz Phospholipid compounds for use in skin cancer treatment
JP2018501322A (ja) 2015-01-12 2018-01-18 チルドレンズ メディカル センター コーポレーション トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041827A2 (en) * 2000-11-24 2002-05-30 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

Also Published As

Publication number Publication date
WO2004006910A1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003243665A1 (en) Dispenser for solid objects
AU2003293632A1 (en) Phenethanolamine derivatives
AU2003299082A1 (en) 1h-imidazo dimers
AU2003215237A1 (en) Solid surface products
AU2003239575A1 (en) Dispenser for rolled material
AU2003203261A1 (en) Ubiquinone-enriched foods
AU2003234440A1 (en) Disposiable dispenser
AU2003213943A1 (en) Flavour-enhanced food product
AU2003247018A1 (en) An arrangement for product display prongs
AU2003265274A1 (en) Package for displaying products
AU2003226058A1 (en) Product dispenser
AU2003220917A1 (en) Phospholipid derivative
AU2002314566A1 (en) Novel curcumin derivatives
AU2003246897A1 (en) Stairlift
AU2003284812A1 (en) Corrugated product
AU2003284053A1 (en) Dispenser
AU2003212525A1 (en) Dispenser
AU2003243806A1 (en) Lipid oxidation products for inhibiting inflammation
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents
AU2003282700A1 (en) Kavalactone product
AU2003266714A1 (en) Phospholipid derivative
AU2003296568A1 (en) Portioned products comprising different constituents
AU2003282232A1 (en) Adornment for comestible products
AU2002333006A1 (en) Pharmaceutical composition comprising carriers for products
AU2002343826A1 (en) Sanitary product

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase